Autres langues

12/08 AP Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
15/05 AP Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
12/05 Delos Capital and AP Biosciences Inc. Launch Collaboration to Create New Biotech Companies Focused on Next-Generation Antibodies
31/03 AP Biosciences, Inc. has filed an IPO in the amount of TWD 1.2562 billion.
23/03 AP Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
22/12 AP Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
12/08/25 AP Biosciences, Inc. Reports Earnings Results for the Half Year Ended June 30, 2025
24/07/25 Designing antibodies to think before they bind
14/05/25 AP Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
29/04/25 AP Biosciences Presents Preclinical Data on P95her/Cd137 T-Cell Engager At American Association of Cancer Research Annual Meeting
22/04/25 AP Biosciences Doses First Patient In Phase 1/2 Clinical Trials Of AP402 For HER2+ Cancer Patients
22/04/25 AP Biosciences Doses First Patient in Phase 1/2 Clinical Trials of AP402 for HER2+ Cancer Patients
21/04/25 AP Biosciences to Present New Preclinical Data at American Association of Cancer Research Annual Meeting
13/08/24 AP Biosciences Inc Reports Earnings Results for the Half Year Ended June 30, 2024
19/03/24 AP Biosciences Inc Reports Earnings Results for the Full Year Ended December 31, 2023
10/08/23 AP Biosciences Inc Reports Earnings Results for the Half Year Ended June 30, 2023
Aucun résultat pour cette recherche
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT